The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges
Abstract
Objective: To evaluate the impact of methicillin resistance in Staphylococcus aureus on mortality, length of hospitalization, and hospital charges. Design: A cohort study of patients admitted to the hospital between July 1, 1997, and June 1, 2000, who had clinically significant S. aureus bloodstream infections. Setting: A 630-bed, urban, tertiary-care teaching hospital in Boston, Massachusetts. Patients: Three hundred forty-eight patients with S. aureus bacteremia were studied; 96 patients had methicillin-resistant S. aureus (MRSA). Patients with methicillin-susceptible S. aureus (MSSA) and MRSA were similar regarding gender, percentage of nosocomial acquisition, length of hospitalization, ICU admission, and surgery before S. aureus bacteremia. They differed regarding age, comorbidities, and illness severity score. Results: Similar numbers of MRSA and MSSA patients died (22.9% vs 19.8%; P = .53). Both the median length of hospitalization after S. aureus bacteremia for patients who survived and the median hospital charges after S. aureus bacteremia were significantly increased in MRSA patients (7 vs 9 days, P = .045; $19,212 vs $26,424, P = .008). After multivariable analysis, compared with MSSA bacteremia, MRSA bacteremia remained associated with increased length of hospitalization (1.29 fold; P = .016) and hospital charges (1.36 fold; P = .017). MRSA bacteremia had a median attributable length of stay of 2 days and a median attributable hospital charge of $6,916. Conclusion: Methicillin resistance in S. aureus bacteremia is associated with significant increases in length of hospitalization and hospital charges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Self-citationHerold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
Gram-Negative Bacteremia: I. Etiology and Ecology
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240029006 · Cited by 1,362
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Guidelines for the prevention of intravascular catheter-related infections
da Silva, G. D., de Almeida, V. S., Querido, D. L., Esteves, A. P. V. D. S., dos Santos, J. P. O., & Rezende, T. F. (2012) · doi:10.5205/3705 · Cited by 1,119
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Self-citationThe Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Self-citationLodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604
Cited by
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Self-citationEmergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Grundmann, H., Aires-de-Sousa, M., Boyce, J., & Tiemersma, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68853-3 · Cited by 1,101
Pathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection
Gordon, R. J., & Lowy, F. D. (2008) · Clinical Infectious Diseases · doi:10.1086/533591 · Cited by 961
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Klein, E., Smith, D. L., & Laxminarayan, R. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1312.070629 · Cited by 862
Patel, G., Huprikar, S., Factor, S. H., Jenkins, S. G., & Calfee, D. P. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/592412 · Cited by 836
Hospital Epidemiology and Infection Control in Acute-Care Settings
Sydnor, E. R. M., & Perl, T. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-10 · Cited by 652
“MSSA and MRSA are normally found colonizing the nares and skin of healthy humans (250, 292).”
BackgroundKöck, R., Becker, K., Cookson, B., van Gemert-Pijnen, J. E., Harbarth, S., Kluytmans, J., Mielke, M., Peters, G., Skov, R. L., Struelens, M. J., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.41.19688-en · Cited by 611
Self-citationKadri, S. S., Adjemian, J., Lai, Y. L., Spaulding, A. B., Ricotta, E., Prevots, D. R., Palmore, T. N., Rhee, C., Klompas, M., Dekker, J. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy378 · Cited by 605
Risk of Acquiring Antibiotic-Resistant Bacteria From Prior Room Occupants
Huang, S. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.18.1945 · Cited by 517
Kullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir124 · Cited by 463
Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals
Robicsek, A., Beaumont, J. L., Paule, S. M., Hacek, D. M., Thomson, R. B., Kaul, K. L., King, P., & Peterson, L. R. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00003 · Cited by 417
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Sunenshine, R. H., Wright, M.-O., Maragakis, L. L., Harris, A. D., Song, X., Hebden, J., Cosgrove, S. E., Anderson, A., Carnell, J., Jernigan, D. B., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060716 · Cited by 411
Self-citationEconomic burden of healthcare-associated infections: an American perspective
Stone, P. W. (2009) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.09.53 · Cited by 394
Mauldin, P. D., Salgado, C. D., Hansen, I. S., Durup, D. T., & Bosso, J. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01041-09 · Cited by 360
The Risk of Infection after Nasal Colonization with Staphylococcus Aureus
Safdar, N., & Bradley, E. A. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.07.034 · Cited by 348
Bauer, K. A., West, J. E., Balada‐Llasat, J., Pancholi, P., Stevenson, K. B., & Goff, D. A. (2010) · Clinical Infectious Diseases · doi:10.1086/656623 · Cited by 347
Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review
Zhen, X., Lundborg, C. S., Sun, X., Hu, X., & Dong, H. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0590-7 · Cited by 337
Clinical and economic burden of antimicrobial resistance
Maragakis, L. L., Perencevich, E. N., & Cosgrove, S. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.751 · Cited by 329
Self-citationGoodman, E. R., Piatt, R., Bass, R., Onderdonk, A. B., Yokoe, D. S., & Huang, S. S. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/588566 · Cited by 309
Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database*
Shorr, A. F., Tabak, Y. P., Killian, A. D., Gupta, V., Liu, L. Z., & Kollef, M. H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239121.09533.09 · Cited by 286
Economic burden of antibiotic resistance: how much do we really know?
Gandra, S., Barter, D. M., & Laxminarayan, R. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12798 · Cited by 281
Antibiotic resistance in Bangladesh: A systematic review
Ahmed, I., Rabbi, M. B., & Sultana, S. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.12.017 · Cited by 277
Liu, S. Q., Yang, C., Huang, Y., Ding, X., Li, Y., Fan, W. M., Hedrick, J. L., & Yang, Y. (2012) · Advanced Materials · doi:10.1002/adma.201202225 · Cited by 255
Higher Risk of Failure of Methicillin-resistant Staphylococcus aureus Prosthetic Joint Infections
Salgado, C. D., Dash, S., Cantey, J. R., & Marculescu, C. E. (2007) · Clinical Orthopaedics & Related Research · doi:10.1097/blo.0b013e3181123d4e · Cited by 254
Thabit, A. K., Crandon, J. L., & Nicolau, D. P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.993381 · Cited by 160
Klein, E. Y., Sun, L., Smith, D. L., & Laxminarayan, R. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws273 · Cited by 155
Morris, D. O., Lautenbach, E., Zaoutis, T., Leckerman, K., Edelstein, P. H., & Rankin, S. C. (2012) · Zoonoses and Public Health · doi:10.1111/j.1863-2378.2011.01448.x · Cited by 91
Wang, L., & Ruan, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-00261-1 · Cited by 63
Williams, G. J., Denyer, S. P., Hosein, I. K., Hill, D. W., & Maillard, J.-Y. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.08.012 · Cited by 57
Evaluation of a Disinfectant Wipe Intervention on Fomite-to-Finger Microbial Transfer
Lopez, G. U., Kitajima, M., Havas, A., Gerba, C. P., & Reynolds, K. A. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.04235-13 · Cited by 34
Metadata
- Authors
- Cosgrove, S. E., Qi, Y., Kaye, K. S., Harbarth, S., Karchmer, A. W., & Carmeli, Y.
- Venue
- Infection Control & Hospital Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2005-02
- Volume
- 26
- Issue
- 2
- Pages
- 166-174
- ISSN
- 0899-823X (ISSN-L)
- 1559-6834
- OpenAlex
- W2133902131
- Cited by
- 856
- References
- 25
- FWCI
- 35.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.